Publication: Ultrasound-triggered local anaesthesia
Loading...
Official URL
Full text at PDC
Publication Date
2017-08-09
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Biomedical Engineering
Abstract
On-demand relief of local pain would allow patients to control the timing, intensity and duration of nerve blocks in a safe and non-invasive manner. Ultrasound would be a suitable trigger for such a system, as it is in common clinical use and can penetrate deeply into the body. Here, we demonstrate that ultrasound-triggered delivery of an anaesthetic from liposomes allows the timing, intensity and duration of nerve blocks to be controlled by ultrasound parameters. On insonation, the encapsulated sonosensitizer protoporphyrin IX produced reactive oxygen species that reacted with the liposomal membrane, leading to the release of the potent local anaesthetic tetrodotoxin. Repeatable ultrasound-triggered nerve blocks were achieved in vivo, with the nerve-block duration depending on the extent and intensity of insonation. There was no detectable systemic toxicity and tissue reaction was benign in all groups. On-demand, personalized local anaesthesia could be beneficial for the management of relatively localized pain states and could potentially minimize opioid use.
Description
UCM subjects
Unesco subjects
Keywords
Citation
1. Epstein-Barash, H. et al. Prolonged duration local anesthesia with minimal
toxicity. Proc. Natl Acad. Sci. USA 106, 7125–7130 (2009).
2. McAlvin, J. B. & Kohane, D. S. in Focal Controlled Drug Delivery (eds. Domb,
A. J. & Khan, W.) 653–677 (Springer US, New York, USA, 2014).
3. Rwei, A. Y. et al. Repeatable and adjustable on-demand sciatic nerve block
with phototriggerable liposomes. Proc. Natl Acad. Sci. USA 112,
15719–15724 (2015).
4. Zhan, C. et al. Phototriggered local anesthesia. Nano Lett. 16, 177–181
(2016).
5. Stolik, S., Delgado, J. A., Pérez, A. & Anasagasti, L. Measurement of the
penetration depths of red and near infrared light in human “ex vivo” tissues.
J. Photochem. Photobiol. B 57, 90–93 (2000).
6. Rwei, A. Y., Wang, W. & Kohane, D. S. Photoresponsive nanoparticles for
drug delivery. Nano Today 10, 451–467 (2015).
7. Smalley, P. J. Laser safety: risks, hazards, and control measures. Laser Ther.
20, 95–106 (2011).
8. Wood, A. K. & Sehgal, C. M. A review of low-intensity ultrasound for cancer
therapy. Ultrasound Med. Biol. 41, 905–928 (2015).
9. Sirsi, S. R. & Borden, M. A. State-of-the-art materials for ultrasoundtriggered
drug delivery. Adv. Drug Deliv. Rev. 72, 3–14 (2014).
10. Marhofer, P. & Chan, V. W. S. Ultrasound-guided regional anesthesia: current
concepts and future trends. Anesth. Analg. 104, 1265–1269 (2007).
11. Abrahams, M. S., Aziz, M. F., Fu, R. F. & Horn, J. L. Ultrasound guidance
compared with electrical neurostimulation for peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials. Br. J. Anaesth. 102,
408–417 (2009).
12. Li, F., Xie, C., Cheng, Z. & Xia, H. Ultrasound responsive block copolymer
micelle of poly (ethylene glycol)–poly (propylene glycol) obtained through
click reaction. Ultrason. Sonochem. 30, 9–17 (2016).
13. Lin, C.-Y., Javadi, M., Belnap, D. M., Barrow, J. R. & Pitt, W. G. Ultrasound
sensitive eLiposomes containing doxorubicin for drug targeting therapy.
Nanomedicine 10, 67–76 (2014).
14. Kim, H. J., Matsuda, H., Zhou, H. & Honma, I. Ultrasound‐triggered smart
drug release from a poly (dimethylsiloxane)–mesoporous silica composite.
Adv. Mater. 18, 3083–3088 (2006).
15. Paris, J. L., Cabañas, M. V., Manzano, M. & Vallet-Regí, M. Polymer-grafted
mesoporous silica nanoparticles as ultrasound-responsive drug carriers.
ACS Nano 9, 11023–11033 (2015).
16. Cintas, P., Tagliapietra, S., Caporaso, M., Tabasso, S. & Cravotto, G. Enabling
technologies built on a sonochemical platform: challenges and opportunities.
Ultrason. Sonochem. 25, 8–16 (2015).
17. Shi, J. et al. Reactive oxygen species—manipulated drug release from a smart
envelope-type mesoporous titanium nanovehicle for tumor sonodynamicchemotherapy.
ACS Appl. Mater. Interfaces 7, 28554–28565 (2015).
18. Kuroki, M. et al. Sonodynamic therapy of cancer using novel sonosensitizers.
Anticancer Res. 27, 3673–3677 (2007).
19. Kennedy, J. C. & Pottier, R. H. Endogenous protoporphyrin IX, a clinically
useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B
14, 275–292 (1992).
20. Jeffes, E. W. B. Levulan®: the first approved topical photosensitizer for the
treatment of actinic keratosis. J. Dermatol. Treat. 13, S19–S23 (2002).
21. Padera, R. F., Tse, J. Y., Bellas, E. & Kohane, D. S. Tetrodotoxin for prolonged
local anesthesia with minimal myotoxicity. Muscle Nerve 34, 747–753 (2006).
22. Sakura, S., Bollen, A. W., Ciriales, R. & Drasner, K. Local anesthetic
neurotoxicity does not result from blockade of voltage-gated sodium
channels. Anesth. Analg. 81, 338–346 (1995).
23. Hagen, N. A. et al. Tetrodotoxin for moderate to severe cancer-related pain: a
multicentre, randomized, double-blind, placebo-controlled, parallel-design
trial. Pain Res. Manag. 2017, 7212713 (2017).
24. Hagen, N. A. et al. A multicentre open-label safety and efficacy study of
tetrodotoxin for cancer pain. Curr. Oncol. 18, E109–E116 (2011).
25. Carter, K. A. et al. Porphyrin–phospholipid liposomes permeabilized by
near-infrared light. Nat. Commun. 5, 3546 (2014).
26. Ericson, M. B., Wennberg, A.-M. & Larkö, O. Review of photodynamic
therapy in actinic keratosis and basal cell carcinoma. Ther. Clin. Risk Manag.
4, 1–9 (2008).
27. Kohane, D. S. et al. The local anesthetic properties and toxicity of saxitonin
homologues for rat sciatic nerve block in vivo. Reg. Anesth. Pain Med. 25,
52–59 (2000).
28. Kohane, D. S. et al. A re-examination of tetrodotoxin for prolonged duration
local anesthesia. Anesthesiology 89, 119–131 (1998).
29. McAlvin, J. B. et al. Corneal anesthesia with site 1 sodium channel blockers
and dexmedetomidine. Invest. Ophthalmol. Vis. Sci. 56, 3820–3826 (2015).
30. Kohane, D. S. et al. Biocompatibility of lipid-protein-sugar particles containing
bupivacaine in the epineurium. J. Biomed. Mater. Res. 59, 450–459 (2002).
31. Marhofer, P., Harrop-Griffiths, W., Willschke, H. & Kirchmair, L. Fifteen years
of ultrasound guidance in regional anaesthesia: part 2-recent developments in
block techniques. Br. J. Anaesth 104, 673–683 (2010).
32. Hayes, B. T., Merrick, M. A., Sandrey, M. A. & Cordova, M. L. Three-MHz
ultrasound heats deeper into the tissues than originally theorized. J. Athl.
Train. 39, 230–234 (2004).
33. Rosenthal, I., Sostaric, J. Z. & Riesz, P. Sonodynamic therapy—a review of the
synergistic effects of drugs and ultrasound. Ultrason. Sonochem. 11, 349–363
(2004).
34. Mišík, V. & Riesz, P. Free radical intermediates in sonodynamic therapy. Ann.
NY Acad. Sci. 899, 335–348 (2000).
35. Leighton, T. G., Pickworth, M. J. W., Walton, A. J. & Dendy, P. P. Studies of
the cavitational effects of clinical ultrasound by sonoluminescence: 1.
Correlation of sonoluminescence with the standing wave pattern in an
acoustic field produced by a therapeutic unit. Phys. Med. Biol. 33,
1239 (1988).
36. Pong, M. et al. In vitro ultrasound-mediated leakage from phospholipid
vesicles. Ultrasonics 45, 133–145 (2006).
37. Schroeder, A., Kost, J. & Barenholz, Y. Ultrasound, liposomes, and drug
delivery: principles for using ultrasound to control the release of drugs from
liposomes. Chem. Phys. Lipids 162, 1–16 (2009).
38. Lin, H.-Y. & Thomas, J. L. Factors affecting responsivity of unilamellar
liposomes to 20 kHz ultrasound. Langmuir 20, 6100–6106 (2004).
39. Voszka, I. et al. Interaction of photosensitizers with liposomes containing
unsaturated lipid. Chem. Phys. Lipids 145, 63–71 (2007).
40. Lyubimtsev, A. et al. Aggregation behavior and UV-vis spectra of tetra-and
octaglycosylated zinc phthalocyanines. J. Porphyr. Phthalocyanines 15,
39–46 (2011).
41. Rokitskaya, T. I., Block, M., Antonenko, Y. N., Kotova, E. A. & Pohl, P.
Photosensitizer binding to lipid bilayers as a precondition for the
photoinactivation of membrane channels. Biophys. J. 78, 2572–2580 (2000).
42. Adams, H. J., Blair, M. R. J. & Takman, B. H. The local anesthetic activity of
tetrodotoxin alone and in combination with vasoconstrictors and local
anesthetics. Anesth. Analg. 55, 568–573 (1976).
43. Lobo, K. et al. A phase 1, dose-escalation, double-blind, block-randomized,
controlled trial of safety and efficacy of neosaxitoxin alone and in
combination with 0.2% bupivacaine, with and without epinephrine, for
cutaneous anesthesia. Anesthesiology 123, 873–885 (2015).
44. Kohane, D. S. Microparticles and nanoparticles for drug delivery. Biotechnol.
Bioeng. 96, 203–209 (2007).
45. Naor, O., Krupa, S. & Shy, S. Ultrasonic neuromodulation. J. Neural Eng. 13,
031003 (2016).
46. Brummett, C. M., Hong, E. K., Janda, A. M., Amodeo, F. S. & Lydic, R.
Perineural dexmedetomidine added to ropivacaine for sciatic nerve block in
rats prolongs the duration of analgesia by blocking the hyperpolarizationactivated
cation current. Anesthesiology 115, 836–843 (2011).
47. Yoshitomi, T. et al. Dexmedetomidine enhances the local anesthetic action of
lidocaine via an α -2A adrenoceptor. Anesth. Analg. 107, 96–101 (2008).
48. Yabuki, A. et al. Locally injected dexmedetomidine induces vasoconstriction
via peripheral α -2A adrenoceptor subtype in guinea pigs. Reg. Anesth. Pain
Med. 39, 133–136 (2014).
49. Curley, J. et al. Prolonged regional nerve blockade. Injectable biodegradable
bupivacaine/polyester microspheres. Anesthesiology 84, 1401–1410 (1996).
50. Kohane, D. S., Lipp, M., Kinney, R. C., Lotan, N. & Langer, R. Sciatic nerve
blockade with lipid-protein-sugar particles containing bupivacaine. Pharm.
Res. 17, 1243–1249 (2000).
51. Castillo, J. et al. Glucocorticoids prolong rat sciatic nerve blockade in vivo
from bupivacaine microspheres. Anesthesiology 85, 1157–1166 (1996).
52. Kohane, D. S. et al. Prolonged duration local anesthesia from tetrodotoxinenhanced
local anesthetic microspheres. Pain 104, 415–421 (2003).
53. Lago, J., Rodriguez, L. P., Blanco, L., Vieites, J. M. & Cabado, A. G.
Tetrodotoxin, an extremely potent marine neurotoxin: distribution, toxicity,
origin and therapeutical uses. Mar. Drugs 13, 6384–6406 (2015).
54. Kohane, D. S., Lu, N. T., Cairns, B. E. & Berde, C. B. Effects of adrenergic
agonists and antagonists on tetrodotoxin-induced nerve block. Reg. Anesth.
Pain Med. 26, 239–245 (2001).
55. Richard, B. M. et al. The safety of EXPAREL® (bupivacaine liposome
injectable suspension) administered by peripheral nerve block in rabbits and
dogs. J. Drug Deliv. 2012, 962101 (2012).
56. Vanrooijen, N. & Vannieuwmegen, R. Liposomes in immunology—
multilamllar phosphatidylcholine liposomes as a simple, biodegradable and
harmless adjuvant without any immunogenic activity of its own. Immunol.
Commun. 9, 243–256 (1980).
57. Rosenberg, G. J. & Cabrera, R. C. External ultrasonic lipoplasty: an effective
method of fat removal and skin shrinkage. Plast. Reconstr. Surg. 105,
785–791 (2000).
58. Pudroma, X., Moan, J., Ma, L.-W., Iani, V. & Juzeniene, A. A comparison of
5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and
protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in
athymic nude mice healthy skin. Exp. Dermatol. 18, 985–987 (2009).
59. Roots, R. & Okada, S. Estimation of life times and diffusion distances of
radicals involved in X-ray-induced DNA strand breaks or killing of
mammalian-cells. Radiat. Res. 64, 306–320 (1975).
60. Pryor, W. A. Oxyradicals and related species—their formation, lifetimes, and
reactions. Annu. Rev. Physiol. 48, 657–667 (1986).
61. Skovsen, E., Snyder, J. W., Lambert, J. D. C. & Ogilby, P. R. Lifetime and
diffusion of singlet oxygen in a cell. J. Phys. Chem. B 109,
8570–8573 (2005).
62. Kohane, D. S. et al. Sciatic nerve blockade in infant, adolescent, and adult
rats: a comparison of ropivacaine with bupivacaine. Anesthesiology 89,
1199–1208 (1998).
63. Rodriguez-Navarro, A. J. et al. Potentiation of local anesthetic activity of
neosaxitoxin with bupivacaine or epinephrine: development of a long-acting
pain blocker. Neurotox. Res. 16, 408–415 (2009).
64. Rodríguez-Navarro, A. J. et al. Comparison of neosaxitoxin versus
bupivacaine via port infiltration for postoperative analgesia following
laparoscopic cholecystectomy: a randomized, double-blind trial. Reg. Anesth.
Pain Med. 36, 103–109 (2011).
65. Alkan-Onyuksel, H. et al. Development of inherently echogenic liposomes as
an ultrasonic contrast agent. J. Pharm. Sci. 85, 486–490 (1996).
66. Shung, K. K. High frequency ultrasonic imaging. J. Med. Ultrasound 17,
25–30 (2009).
67. Jaafar-Maalej, C., Diab, R., Andrieu, V., Elaissari, A. & Fessi, H. Ethanol
injection method for hydrophilic and lipophilic drug-loaded liposome
preparation. J. Liposome Res. 20, 228–243 (2010).
68. Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and
purification. Can. J. Biochem. Physiol. 37, 911–917 (1959).
69. Da Costa, M. M. J. et al. A new zebrafish model produced by TILLING of
SOD1-related amyotrophic lateral sclerosis replicates key features of the
disease and represents a tool for in vivo therapeutic screening. Dis. Model.
Mech. 7, 73–81 (2014).
70. Wu, D. & Yotnda, P. Production and detection of reactive oxygen species
(ROS) in cancers. J. Vis. Exp. 3357 (2011).
71. Jiang, Z.-Y., Woollard, A. C. & Wolff, S. P. Lipid hydroperoxide measurement
by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the
TBA assay and an iodometric method. Lipids 26, 853–856 (1991).
72. Rouhi, N., Jain, D., Zand, K. & Burke, P. J. Carbon nanotube field effect
transistors using printed semiconducting tubes. Nanotechnology 1,
180–182 (2010).
73. Liang, X., Mao, G. & Ng, K. Y. S. Mechanical properties and stability
measurement of cholesterol-containing liposome on mica by atomic force
microscopy. J. Colloid Interface Sci. 278, 53–62 (2004).
74. Zimmermann, M. Ethical guidelines for investigations of experimental pain
in conscious animals. Pain 16, 109–110 (1983).
75. Rwei, A. Y., Zhan, C., Wang, B. & Kohane, D. S. Multiply repeatable and
adjustable on-demand phototriggered local anesthesia. J. Control. Release 251,
68–74 (2017).
76. Thalhammer, J., Vladimirova, M., Bershadsky, B. & Strichartz, G. Neurologic
evaluation of the rat during sciatic nerve block with lidocaine. Anesthesiology
82, 1013–1025 (1995).
77. McAlvin, J. B. et al. Multivesicular liposomal bupivacaine at the sciatic nerve.
Biomaterials 35, 4557–4564 (2014).